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During mammalian brain development, the ventricular zone of the dorsolateral region of the alar telencephalon (neocortex) contains undifferentiated neural progenitor cells that initially undergo symmetric (proliferative) divisions to generate two new progenitor cells and later undergo asymmetric (differentiative) divisions to give rise to a new mitotic progenitor and a post-mitotic neuron. 1, 2 Precise regulation of the balance between the undifferentiated progenitor state and neuronal differentiation in the embryonic neocortex is essential for the correct development of the adult cerebral cortex, but the mechanisms regulating the progenitor-to-neuron transition in this brain region remain incompletely characterized.
Transcriptional repressors of the Hairy/Enhancer of split (Hes) family are important regulators of the balance between proliferation and differentiation during mouse cortical neurogenesis. Specifically, Hes1 acts downstream of Notch receptors to inhibit neuronal differentiation and promote maintenance of the undifferentiated state. [3] [4] [5] In both invertebrate and vertebrate species, Notch-induced Hes proteins, such as Hes1, repress transcription together with the general transcriptional corepressors of the Groucho/transducin-like Enhancer of split (Gro/TLE) family. [6] [7] [8] Gro/TLE1 is expressed in undifferentiated cortical neural progenitor cells in which Hes1 is also expressed [9] [10] [11] and inhibits cortical neuronal differentiation in vivo and in vitro. [10] [11] [12] Moreover, Hes1 and Gro/TLE1 physically interact, repress transcription together and localize to common promoter regions in vivo. [13] [14] [15] Hes1 and Gro/TLE1 are expressed in neural progenitor cells during both the proliferative and differentiative phases of cortical neurogenesis, suggesting the existence of mechanisms that either promote or inhibit their anti-neurogenic function at different stages of cortical neuronal differentiation. Hes1 binds to the C-terminal WD40 repeat-containing domain of Gro/TLE1 through its own C-terminal tetrapeptide, WRPW. 7, 16 Complex formation with Hes1 results in Gro/ TLE1 recruitment to DNA, 14, 15 where Gro/TLE1 interacts with structural chromatin components. 17 In addition, Hes1 binding causes increased Gro/TLE1 phosphorylation, a process previously termed 'cofactor-activated phosphorylation'. 11, 18 Inhibition of cofactor-activated phosphorylation by mutation of selected serine residues within the serine/proline-rich domain of Gro/TLE1 weakens the interaction of Gro/TLE1 with chromatin and impairs both the transcriptional repression ability and anti-neurogenic activity of this protein without affecting its interaction with Hes1. Thus, cofactor-activated phosphorylation of Gro/TLE1 induced by the binding of Hes1 has a positive role in the anti-neurogenic activity of the Gro/ TLE1:Hes1 complex.
In this study, we sought to characterize additional molecular mechanisms underlying the regulation of Gro/TLE1:Hes1 function during cortical neuronal differentiation. Here we provide evidence that the phosphorylation-dependent prolyl isomerase Pin1 (peptidyl-prolyl cis-trans isomerase NIMAinteracting 1), which recognizes phosphorylated Ser/Thr-Pro sites and catalyzes proline cis/trans isomerization, 19, 20 and the protein kinase homeodomain-interacting protein kinase 2 (HIPK2) 21, 22 are expressed during cortical neurogenesis and form a complex. The Pin1:HIPK2 complex interacts with Gro/TLE1:Hes1 and inhibits the anti-neurogenic function of these proteins during cortical neuronal differentiation. These findings reveal a previously uncharacterized role for a complex of Pin1 and HIPK2 in the promotion of cortical neurogenesis at least in part by antagonizing Gro/TLE1:Hes1-mediated inhibition of neuronal differentiation.
Results
Pin1 interacts with Gro/TLE1 in the developing cerebral cortex and is important for cortical neuronal differentiation. Gro/TLE1 undergoes increased phosphorylation during neurogenesis 18, 23 and contains several putative Ser-Pro and Thr-Pro phosphorylation sites. At least one of these sites, 286 Ser-Pro, is phosphorylated in vivo, 15 suggesting that Gro/TLE1 might be a substrate for the ubiquitous prolyl isomerase Pin1. This enzyme catalyzes proline cis/trans isomerization at phosphorylated Ser/Thr-Pro sites, a process that often results in conformational changes that modulate the activity of the Pin1 protein substrates. 19, 20 We observed that in mouse embryos at embryonic day (E) 13.5, a period of active cortical neuronal differentiation, endogenous Pin1 was coexpressed with endogenous Gro/ TLE proteins in both the ventricular zone of the cerebral cortex, where undifferentiated neural progenitor cells are located, and in the developing cortical plate, where migrated post-mitotic neurons come to reside (Figure 1a ). Overlapping expression of Pin1 and Gro/TLE was also observed in primary cultures of cortical neural progenitor cells established from E13.5 mouse embryos (Supplementary Figure  S1a) . More importantly, immunoprecipitation of endogenous Gro/TLE1 from mouse cerebral cortices dissected at E13.5 resulted in the coprecipitation of endogenous Pin1 (Figure 1b) . Together, these results show that Pin1 and Gro/TLE1 are coexpressed and interact during cerebral cortex neurogenesis. On the basis of these observations, we examined whether the association of Gro/TLE1 with Pin1 might be modulated by Hes1, a key mediator of Gro/TLE1 anti-neurogenic activity. 11, 12, 14, 18 HEK293 cells, which express endogenous Gro/TLE1 and Hes1, 15, 18 were transfected with Pin1 and Gro/ TLE1 in the absence or presence of exogenous Hes1, followed by immunoprecipitation with anti-Gro/TLE1 antibody. Both Hes1 and Pin1 coprecipitated with Gro/TLE1, and Pin1 associated more efficiently with Gro/TLE1 in the presence of increased levels of Hes1 (Figure 1c ). These observations provide evidence that Hes1 is important for the association of Pin1 with Gro/TLE1.
To begin to investigate the involvement of Pin1 in the antineurogenic function of the Gro/TLE1:Hes1 complex, we determined the effect of Pin1 inhibition on cortical neuronal differentiation in vitro. Pharmacological inhibition of endogenous Pin1 in primary cultures of cortical progenitor cells using the reagent juglone 24 caused a reduced generation of cells expressing the neuronal markers MAP2 and type III b-tubulin and a parallel accumulation of cells expressing the proliferation marker Ki67 and the undifferentiated neural progenitor marker nestin, compared with control conditions (Figures 1d and e) . Consistent with these results, exposure of cortical progenitor cells to juglone caused both increased levels of phosphorylated histone H3, a marker of mitotic cells, and decreased amounts of type III b-tubulin and GAP-43, another protein expressed in differentiated neurons (Figure 1f ). The same effects were observed after silencing of Pin1 in cortical progenitor cells using lentiviral-mediated expression of a Pin1 short hairpin (sh) RNA reagent, but not when a control non-silencing shRNA was used (Figure 1g ). Taken together with the demonstration that knockout of mouse Pin1 causes decreased neuronal differentiation in cultured cortical progenitor cells, 25 these results show that Pin1 promotes cortical neurogenesis. Moreover, they provide evidence that Gro/TLE1:Hes1 and Pin1 have opposite biological functions during cortical neuronal development.
Pin1 interacts with Gro/TLE1:Hes1 complex together with HIPK2. To characterize the mechanisms underlying Pin1 interaction with Gro/TLE1, we focused on the protein kinase HIPK2, which commonly phosphorylates Ser/Thr-Pro sites 21 and was implicated in the phosphorylation of Gro/TLE in Drosophila. 26, 27 Endogenous Gro/TLE1, Pin1 and HIPK2 were expressed in dissected cerebral cortices from E13.5 mouse embryos (Supplementary Figure S1b) . Furthermore, HIPK2 was coexpressed with both Gro/TLE1 and Pin1 in primary cultures of cortical neural progenitor cells ( Supplementary Figures S1c and d) . More importantly, immunoprecipitation of Pin1 from HEK293 cells transfected with Gro/TLE1, Hes1 and HIPK2 resulted not only in the coprecipitation of the former three proteins but also in the specific coprecipitation of HIPK2 ( Figure 2a , lane 5; and Supplementary Figure S2 ). The coprecipitation of Gro/TLE1 and Hes1 with Pin1 was significantly weaker, or even undetectable, in the absence of exogenous HIPK2 or in the presence of a catalytically inactive form of HIPK2, termed HIPK2(K221R) 28 ( Figure 2a ; see lanes 4-6). As previously shown, the catalytically inactive form of HIPK2 migrated faster than wild-type HIPK2. 26 Moreover, neither Gro/TLE1 nor Hes1 coprecipitated with Pin1 and HIPK2 when Hes1 was mutated to prevent Gro/TLE1 binding by deleting the C-terminal WRPW sequence required for binding to Gro/TLE (Hes1DWRPW) 13, 15, 29, 30 ( Figure 2a ; see lanes 5 and 7), suggesting further that Pin1 interacts with the Gro/TLE1:Hes1 complex, rather than with Gro/TLE1 or Hes1 alone.
These studies also revealed that both HIPK2 and HIPK2(K221R) readily coprecipitated with Pin1 irrespective of the coprecipitation of Gro/TLE1 and Hes1, showing that HIPK2 and Pin1 form a complex (Figure 2a , see lanes 5-7). The Pin1:HIPK2 interaction was dependent on the prolyl isomerase enzymatic activity of Pin1, because immunoprecipitation of a catalytically inactive Pin1 mutant, termed Pin1(S67E), 31 did not result in the coprecipitation of HIPK2, Figure 3a ; see lanes 1 and 2; 4 and 5). The shift in Gro/TLE1 mobility induced by either Hes1 or Runx1 was enhanced by the coexpression of HIPK2 (Figure 3a ; see lanes 2 and 3; 5 and 6). The HIPK2-mediated increase of more slowly migrating Gro/TLE1 was abolished in the presence of calf intestinal phosphatase, showing that it was the result of hyperphosphorylation (Figure 3b ; see lanes 3 and 6). Consistent with this result, we observed no effect on Gro/TLE1 gel mobility when the catalytically inactive HIPK2(K221R) was used (Figure 3c On the basis of these results, we determined whether the requirement of Hes1 binding for HIPK2-mediated phosphorylation of Gro/TLE1 reflected a need for either prior complex formation between Hes1 and Gro/TLE1 or prior Hes1-induced cofactor-activated phosphorylation of the latter. To distinguish between these possibilities, we uncoupled these two events by taking advantage of previously described Gro/ TLE1 proteins harboring point mutations that reduce/block cofactor-activated phosphorylation without interfering with the binding of Gro/TLE1 to Hes1. Two separate proteins, Gro/TLE1(S239A) and Gro/TLE1(S298A), previously shown to display a markedly decreased cofactor-activated phosphorylation 11, 15 ( Figure 3d (i-iii), see lanes 1 and 2), underwent a significant electrophoretic mobility shift in the presence of HIPK2, suggesting that they were still competent to undergo HIPK2-mediated phosphorylation ( Figure  3d (ii and iii), lane 3). Two other mutated Gro/TLE proteins, Gro/TLE1(S286A) and Gro/TLE1(S289A), carrying point mutations that completely block cofactor-activated phosphorylation, 15 exhibited a detectable gel retardation in the presence of HIPK2 but not HIPK2(K221R) (Figure 3d (iv and v), lanes 3 and 4). This mobility shift was also observed when Ser-286 was mutated to Glu (S286E), a mutation that also completely blocks Gro/TLE1 cofactor-activated phosphorylation but not Hes1 binding 15 ( Figure 3e , see lanes 4-6). Both Gro/TLE1(S286A) and Gro/TLE1(S286E) coprecipitated with Pin1, HIPK2 and Hes1 similar to wild-type Gro/TLE1 (Figure 3e , see lanes 3, 5 and 6). Together, these findings show that HIPK2 mediates Gro/TLE1 hyperphosphorylation in a Hes1-dependent manner. This requirement is not due to a necessity for prior Hes1-induced cofactor-activated phosphorylation of Gro/TLE1 and likely underscores a need for Hes1 binding-mediated conformational changes in Gro/TLE1.
Pin1 and HIPK2 weaken the transcriptional repressor activity of Gro/TLE1:Hes1. We next determined the effect of HIPK2-mediated Gro/TLE1 hyperphosphorylation on the transcriptional repressor function the Gro/TLE1:Hes1 complex. We observed that the previously demonstrated [11] [12] [13] ability of Hes1 to repress transcription in cells in which Gro/TLE proteins are endogenously expressed was blocked by a dominant-negative form of Gro/TLE, termed Gro/TLE1DQ, 32 showing that Hes1-mediated transcriptional repression depends on Gro/TLE corepressor activity (Figure 4a To determine the mechanisms underlying this inhibitory effect, we examined whether HIPK2 might weaken the association of Gro/TLE1 with Hes1 (Gro/TLE binding-incompetent Hes1DWRPW was used as a negative control). Coimmunoprecipitation experiments showed that neither HIPK2 nor HIPK2(K221R) had a detectable effect on the formation of the Gro/TLE1:Hes1 complex ( Figure 4d , see lanes 4-6). As shown previously, 18 Gro/TLE1 was recovered more robustly in the cell lysates when Hes1DWRPW was used, due to the lack of Hes1-mediated DNA recruitment and association with chromatin ( Figure 4d , see lanes 2 and 3). These results suggest that HIPK2-mediated phosphorylation does not interfere with the association of Gro/TLE1 with Hes1.
We therefore examined whether HIPK2 might exert a negative effect on the association of Gro/TLE1:Hes1 with chromatin. Using a biochemical fractionation approach previously adopted to separate the chromatin-bound Gro/TLE1 population from the chromatin-unbound portion, 12, 18, 23 we observed that Gro/TLE1 was recovered mainly in the nonchromatin ('post-nuclear supernatant') fraction in the absence of Hes1, whereas a significant amount of Gro/TLE1 was found in the chromatin fraction together with Hes1 ( Figure 5a In agreement with the previous findings, chromatin immunoprecipitation (ChIP) experiments showed that binding of exogenous FLAG-tagged Hes1 to the promoter of the ASCL1 gene, a previously described transcriptional target of Hes1, 14 was significantly reduced in the presence of exogenous Pin1 and HIPK2 (Figure 5c , see lanes 2 and 6; Figure 5d ). Moreover, electrophoretic mobility shift assays showed that the mobility of a double-stranded oligonucleotide containing two Hes1 binding sites was retarded in the presence of exogenous Hes1 and that this mobility shift was abolished by the coexpression of Pin1 and HIPK2 (Figure 5e , see lanes 4 and 6). The exogenous expression of HIPK2 alone had a weaker effect, suggesting that the observed outcome was mediated by a Pin1:HIPK2 complex (Figure 5e , see lanes 4-6). Taken together, these findings show that Pin1 and HIPK2 act as negative regulators of the transcriptional repressor activity of the Gro/TLE1:Hes1 complex, at least in part by weakening the association of the latter with chromatin.
Pin1 and HIPK2 inhibit the anti-neurogenic activity of Gro/TLE1:Hes1. On the basis of the previous results, we examined whether Pin1 and HIPK2 would antagonize the anti-neurogenic activity of Gro/TLE1:Hes1. This possibility was first examined in SH-SY5Y neuroblastoma cells, which can be induced to undergo neuronal differentiation in vitro upon treatment with retinoic acid. 33, 34 SH-SY5Y cells do not normally express the protein Tau, a marker of differentiated neurons, but expression of this protein is induced by treatment with retinoic acid 34, 35 ( Figure 6a , left-hand panel). We first compared the numbers of retinoic acid-treated SH-SY5Y cells expressing either Ki67 or Tau after transfection of plasmids expressing green fluorescent protein (GFP) alone (control) or together with Gro/TLE1 and Hes1. Exogenous Gro/TLE1:Hes1 caused a reduction in the number of Tau-positive SH-SY5Y cells and a parallel To confirm these observations, we examined the effect of Pin1 and HIPK2 on the anti-neurogenic activity of Gro/TLE1 and Hes1 in primary cultures of cortical progenitor cells. Figure S4) . Coexpression of either Pin1 alone or HIPK2 alone showed a trend toward a reduced anti-neurogenic effect by Gro/TLE1 and Hes1, but these results were not as pronounced as when Pin1 and HIPK2 were expressed together (Figures 6b-e , bars 5 and 6 in right-hand panels; Supplementary Figure S4) . Together, these results provide evidence that Pin1 and HIPK2 can antagonize the anti-neurogenic activity of the Gro/TLE:Hes1 complex in cortical neural progenitor cells.
Discussion
The anti-neurogenic activity of Gro/TLE1 depends on two sequential events, basal phosphorylation and cofactor (e.g., Hes1)-activated phosphorylation. Together, these processes establish a post-translational modification state that mediates strong association of Gro/TLE1-containing complexes with chromatin and optimal transcriptional repression function 11, 15, 18 ( Figure 7) . In this study, we have obtained evidence that Hes1 binding not only triggers the cofactoractivated phosphorylation of Gro/TLE1 but also promotes the association of the Gro/TLE1:Hes1 complex with Pin1 and HIPK2 ( Figure 7 ). This higher-order association depends on the formation of a complex of Gro/TLE1 and Hes1 and also on the enzymatic activity of Pin1 (required for the Pin1:HIPK2 interaction) and the catalytic activity of HIPK2 (needed for Pin1:HIPK2 association with Gro/TLE1:Hes1).
The recruitment of Pin1 and HIPK2 to the Gro/TLE1:Hes1 complex leads to Gro/TLE1 hyperphosphorylation. This effect requires the catalytic activity of HIPK2 and does not occur in the absence of Hes1. The latter observation raised the possibility that the Pin1:HIPK2 complex might be recruited to Gro/TLE1 through Pin1-mediated binding to Ser/ThrPro site(s) generated by Hes1-mediated cofactor-activated phosphorylation. However, our studies have shown that cofactor-activated phosphorylation in response to Hes1 binding is not required for the association of Gro/TLE1:Hes1 with Pin1 and HIPK2, suggesting instead that Hes1 binding induces conformational changes in Gro/TLE1 that expose previously unavailable Ser/Thr-Pro site(s) that become phosphorylated by HIPK2. It is possible that Hes1 might also be a substrate of HIPK2-mediated phosphorylation because Hes1 electrophoretic mobility was reduced in the presence of HIPK2, but not the catalytically inactive form of HIPK2. However, this possibility remains to be determined.
Our results suggest that HIPK2-mediated phosphorylation of Gro/TLE1 has the potential to generate phosho-Ser/ThrPro sites that may become targets of the enzymatic activity of Pin1 bound to HIPK2 (Figure 7) . Although the possibility that Gro/TLE1 (and possibly Hes1) might be a substrate of Pin1 prolyl isomerase activity remains to be tested, it is reasonable to speculate that Pin1 could then mediate prolyl isomerization events at those specific sites, leading to conformational changes that could in turn modulate the biochemical activity of Gro/TLE1:Hes1.
We have also provided evidence that Pin1 and HIPK2 impair transcriptional repression mediated by Gro/ TLE1:Hes1. This effect, likely the result of changes in phosphorylation or/and isomerization at specific Ser/Thr-Pro sites, is caused at least in part by the weakening of the binding of Gro/TLE1:Hes1 to DNA. Interestingly, electrophoretic mobility shift assays have shown that the expression of Pin1 and HIPK2 abolishes DNA binding by Hes1, suggesting that Hes1 could be directly modified by HIPK2 or Pin1 (or both). It should be mentioned, however, that because the cell lysates used in these experiments contained endogenous Gro/TLE, the observed effect might have been mediated by posttranslational modifications of Gro/TLE present in a complex with Hes1.
The present studies have shown further that the negative effect of Pin1 and HIPK2 on the transcriptional repression activity of the Gro/TLE1:Hes1 complex is biologically relevant in the context of cortical neuronal differentiation. Gro/TLE1, Hes1, Pin1 and HIPK2 are expressed in undifferentiated cortical neural progenitor cells during the neurogenic phase. Endogenous Gro/ TLE1 and Pin1 form a complex in the mouse cerebral cortex during active neuronal differentiation, when mechanisms must be in place to limit the anti-neurogenic function of Gro/TLE1 and Hes1. Pharmacological inhibition, or shRNA-mediated silencing, of Pin1 activity in cortical progenitor cells causes decreased neuronal differentiation and increased numbers of cells expressing markers of the undifferentiated neural progenitor state, in agreement with recent studies showing that Pin1 knockout in mice decreases neuronal differentiation in cultured neural progenitor cells. 25 More importantly, we have shown that expression of Pin1 and HIPK2 blocks the ability of Gro/ TLE1:Hes1 to inhibit neuronal differentiation in both retinoic acid-treated SH-SY5Y neuroblastoma cells and primary cultures of cortical neural progenitor cells.
In summary, the present studies provide evidence that Pin1 and HIPK2 form a complex important for the regulation of cortical neurogenesis. We propose that these enzymes act, at least in part, to mediate post-translational modifications that impair the transcriptional repression activity of Gro/TLE1:Hes1, thereby antagonizing the anti-neurogenic function of these proteins in the developing cerebral cortex. In this model, Hes1 binding sets in motion a Gro/TLE1 'phosphorylation crescendo' that first ensures that the Gro/ TLE1:Hes1 complex is recruited to specific DNA sites in a transcriptional repression-competent state and then predisposes this complex to subsequent Pin1:HIPK2-mediated post-translational modifications (Figure 7 ). These events act as either positive or negative switches, respectively, in the regulation of the biological activity of Gro/TLE1:Hes1 during cortical neurogenesis.
Materials and Methods DNA plasmids. The following expression and reporter plasmids were used: pCMV2-FLAG-Gro/TLE1, 11 pCMV2-FLAG-Gro/TLE1(S239A), 11 pCMV2-FLAG-Gro/TLE1(S286A), 15 pCMV2-FLAG-Gro/TLE1(S286E), 15 pCMV2-FLAGGro/TLE1(S289A), 15 pCMV2-FLAG-Gro/TLE1(S298A), 15 pCMV2-FLAG-Gro/ TLE1DQ, 32 pCMV2-FLAG-Hes1, 13 pCMV2-FLAG-Hes1(DWRPW), 13 pRc-CMVHes1, 15 pCMV2-FLAG-Runx1, 36 pFLAG-HIPK2(WT), 31 pFLAG-HIPK2(K221R), 31 pcDNA3-Pin1-HA, 31 pcDNA3-Pin1(S67E)-HA, 31 pEGFP, 11,12,37 pFOX-Neurogenin3-promoter-luciferase 37 and pRSV-b-galactosidase. Coronal sections through E13.5 mouse brains were rinsed twice in HEPESbuffered saline and then preincubated for 1 h in blocking solution, which was provided by the 'mouse-on-mouse' (MOM) kit purchased from Vector Laboratories Inc (Burlingame, CA, USA). Sections were then incubated for 1-2 h at room temperature in blocking solution containing rat anti-Gro/TLE 11, 12, 32, 38 (i.e., 'panTLE'; 1 : 20) and rabbit anti-Pin1 39 (1 : 500) antibodies.
Cell line culture, transfection, lysis and phosphatase treatment.
Human embryonic kidney HEK293 cells were cultured, transfected using the SuperFect reagent and subjected to cell lysis as described. [11] [12] [13] Treatment of cell lysates with calf intestinal phosphatase was performed as described. 23 Coimmunoprecipitation. For immunoprecipitation of endogenous proteins, dissected alar telencephalon from E13.5 CD1 mouse embryos was rinsed in ice-cold Hank's balanced salt solution and then incubated in 10 packed-tissue volumes of lysis buffer (25 mM Tris/HCl, pH 7.8, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100) supplemented with 'Complete' protease inhibitor cocktail (Roche Applied Science, Laval, QC, Canada), and 1 mM PMSF. Tissue was mechanically triturated and incubated for 15 min on ice, followed by centrifugation at 14 000 Â g for 15 min. The supernatant was recovered and subjected to immunoprecipitation of endogenous Gro/TLE1 using rabbit anti-Gro/TLE1 10, 12, 23 or control rabbit serum using protein A/G-Plus agarose beads (Santa Cruz Biotechnology, Santa Cruz, CA, USA). Collected and thoroughly rinsed immunoprecipitates were resuspended in 60 mM Tris/HCl, pH 6.8, 10% glycerol and 2% SDS, followed by incubation at room temperature for 10 min and recovery of the eluted material by quick centrifugation. Eluates, together with 1/10 of input lysate, were incubated in the presence of 100 mM dithiothreitol, followed by SDS-polyacrylamide gel electrophoresis, transfer to nitrocellulose and western blotting with mouse anti-Pin1 (1 : 2000; R&D Systems, Minneapolis, MN, USA) and rabbit anti-Gro/TLE1 (1;1000) antibodies. For immunoprecipitation of epitope-tagged proteins, HEK293 cells were transfected with plasmids pCMV2-FLAG-Gro/TLE1 (200 ng/transfection) and pCMV2-FLAG-Hes1 (or pCMV2-FLAG-Hes1(DWRPW)) (200 ng/transfection) in the absence or presence of pcDNA3-Pin1-HA (or pcDNA3-Pin1(S67E)-HA) (400 ng/transfection) and pFLAG-HIPK2(WT) (or pFLAG-HIPK2(K221R)) (400 ng/ transfection), followed by preparation of cell lysates and immunoprecipitation with either rabbit anti-Gro/TLE1, mouse anti-HA (Covance, Emeryville, CA, USA) or preimmune serum as described. 11, 12, 15 Immunoprecipitates were analyzed Figure 7 Proposed model of regulation of Gro/TLE1:Hes1 complex. (a) Gro/TLE1 is a basally phosphorylated ('bP'; yellow circle) protein 18 that lacks DNA-binding activity but becomes recruited to specific target genes through association with Hes1. The interaction with Hes1 leads to cofactor-activated phosphorylation ('caP'; green circle) of Gro/TLE1, which results in increased affinity of Gro/TLE1 for chromatin components and optimal transcriptional repression activity. 11, 15, 18 Binding of Hes1 also induces changes in Gro/TLE1 conformation that expose previously unavailable phosphorylation sites. (b) The Gro/TLE1:Hes1 complex is recognized by the HIPK2:Pin1 complex in a manner that depends on the binding of Hes1 to Gro/TLE1. This event results in HIPK2-mediated hyperphosphorylation ('hP'; red circle) of Gro/TLE1 creating new phosphorylated Ser/Thr-Pro site(s) that are bound by Pin1. HIPK2 may also mediate phosphorylation of Hes1 but this possibility remains to be determined. HIPK2-mediated hyperphosphorylation and/or Pin1-mediated isomerization of specific Ser/Thr-Pro site(s) weaken the interaction of the Gro/TLE1:Hes1 complex with chromatin, thereby inhibiting Gro/TLE1:Hes1-mediated transcriptional repression together with each input lysate collected before immunoprecipitation by western blotting using mouse anti-FLAG (1 : 10 000; Sigma-Aldrich, St. Louis, MO, USA), mouse anti-HA (1 : 5000) or rat anti-Gro/TLE (1 : 20) antibodies.
Biochemical fractionation. Post-nuclear supernatants and chromatinenriched fractions were obtained as described previously. 17 Subcellular fractions were analyzed by western blotting using anti-FLAG, anti-Gro/TLE or anti-HA antibodies.
Transient transfection/transcription assays. HEK293 cells were transfected using the SuperFect reagent. In all cases, the total amount of transfected DNA was adjusted at 3.0 mg per well using empty pcDNA3 plasmid. Cells were transfected with the pFOX-Neurogenin3-promoter-luciferase construct (1.0 mg/transfection) alone or together with pCMV2-FLAG-Hes1 (50 ng/transfection) in the absence or presence of pCMV2-FLAG-Gro/TLE1 (100 ng/transfection), pCMV2-FLAG-Gro/TLE1DQ (200 ng/transfection), pcDNA3-Pin1-HA (400 ng/transfection), pFLAG-HIPK2(WT) (400 ng/transfection) or pFLAG-HIPK2(K221R) (400 ng/transfection), as indicated in the appropriate figure legend. In each case, 250 ng/transfection of b-galactosidase expression plasmid, pRSV-bgal, was used to normalize for transfection efficiency. Twenty-four hours after transfection, cells were subjected to determination of luciferase activity as described.
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Chromatin immunoprecipitation. ChIP experiments were performed using the Magna ChIP G chromatin immunoprecipitation kit (Millipore, Billerica, MA, USA). All steps were performed according to the manufacturer's instructions. HEK293 cells were transfected with pCMV2-FLAG-Hes1 (25 ng/transfection) alone or together with pFLAG-HIPK2 (100 ng/transfection) and pcDNA3-Pin1-HA (100 ng/transfection), followed by cross-linking for 10 min using formaldehyde, sonication to yield 200-500 bp fragments and immunoprecipitation with either anti-FLAG antibody or the following control, irrelevant, antibodies: anti-HA and mouse anti-glutathione S-transferase (Santa Cruz Biotechnology). Chromatin:antibody complexes were harvested using protein G magnetic beads and a magnetic separator, washed extensively and incubated at 62 1C in the presence of 'ChIP Elution Buffer' containing 0.1 mg/ml proteinase K to reverse the cross-linking and to recover the DNA. Immunoprecipitated DNA was purified using spin columns and reagents supplied with the Magna ChIP G kit and analyzed for the human ASCL1 promoter sequence by PCR using oligonucleotide primers whose respective 5 0 ends were located 546 bp (primer ASCL1p-F) and 170 bp (primer ASCL1p-R) upstream from the starting ATG codon, resulting in a product of 376 bp. The amplified region contains two tandem copies 5 0 -CACGCGAGCGCCACGCG-3 0 of the N-box, a canonical Hes binding site. These sequences correspond to the two previously described tandem Hes1-binding sites in the proximal region of the rat Ascl1 gene. 14 The sequence of the oligonucleotide primers was as follows:
Quantitative PCR. Products of ChIP experiments were analyzed by q-PCR using the CFX96 Touch Real-Time PCR Detection System using SsoFast EvaGreen Supermix (Bio-Rad Laboratories, Hercules, CA, USA). The following oligonucleotides were used: ASCL1p-F2:
Values were calculated as fold enrichment of each condition over the ChIP data obtained using the anti-GST antibody as control.
Electrophoretic mobility shift assay. Reactions were performed in a volume of 20 ml containing a gel shift binding buffer provided by the 'LightShift Chemiluminescent EMSA kit' (Pierce Biotechnology, Rockford, IL, USA), 50 ng/ml poly-(dI:dC) and 4 mg of nuclear extracts. A double-stranded oligonucleotide containing two tandem N-box sequences (sense strand: 5 0 -CTAGACGCCAC GAGCCACAAGGATTG-3 0 ; antisense strand: 5 0 -CTAGCAATCCTTGTGGCTCGT GGCGT-3 0 ) was labeled at 3 0 -ends with biotin (Integrated DNA Technologies, Toronto, ON, Canada) and used as a probe (B10 fmol). Samples were incubated for 20 min at 22 1C before electrophoresis on 5% polyacrylamide gels (29 : 1 acrylamide:bis-acrylamide) in 0.5X TBE buffer.
Retinoic acid-induced neuronal differentiation of neuroblastoma cells. Human neuroblastoma SH-SY5Y cells 34, 35, 40 were cultured and transfected with plasmids encoding GFP and the combinations of proteins indicated in the appropriate figure legend using the HD Fugene reagent (Roche Applied Science). Neuronal differentiation was induced by the treatment of SH-SY5Y cells with 10 mM retinoic acid for 3 days. After this time, cells were subjected to doublelabel immunofluorescence analysis of the expression of GFP and either Ki67 or Tau using the following antibodies: mouse anti-Ki67 (1 : 500; BD Pharmingen, San Diego, CA, USA) or mouse anti-Tau (1 : 100; Millipore).
Primary cultures of cortical neural progenitor cells. Primary neural progenitor cells from E13.5 mouse neocortices were obtained and cultured as described.
11,12,37 Double-label immunofluorescence analysis of endogenous proteins was performed as described 11, 41 using the following primary antibodies: rat anti-Gro/TLE (1 : 10), rabbit anti-Pin1 (1 : 500), mouse anti-Pin1 (1 : 200; R&D Systems) or rabbit anti-HIPK2 42 (1 : 300). For differentiation assays, cells were transfected as described 11, 12, 37 after 48 h in vitro using the following plasmids in the combinations indicated in the appropriate figure legend: pEGFP (0.1 mg/well) alone or in combination with pCMV2-FLAG-Gro/TLE1 (0.4 mg/well), pCMV2-FLAGHes1 (0.4 mg/well), pFLAG-HIPK2 or pFLAG-HIPK2(K221R) (0.4 mg/well) and pcDNA3-Pin1-HA (0.4 mg/well). The pEGFP plasmid was always present at a 1 : 4 ratio compared with the effector plasmids, a strategy that results in greater than 90% of transfected cells coexpressing GFP and the proteins of interest. 11, 12, 15, 37 Three days following transfection, cells were analyzed by immunofluorescence using antibodies against Ki67 (1 : 500; BD Pharmingen), nestin (1 : 100; Millipore), Sox2 (1 : 250; R&D Systems), type III b-tubulin (1 : 1000; Promega, Madison, WI, USA), MAP2 (1 : 1000; Sigma-Aldrich) and NeuN (1 : 250; Millipore), as described. 41, 43 Cells were counterstained with Hoechst 33258 (Sigma-Aldrich) before examination by fluorescence microscopy. Grayscale images were digitally assigned to the appropriate red or green channel using Northern Eclipse software (Empix Imaging, Inc., Mississauga, ON, Canada). Three to six random fields of each condition (per experiment) were used for quantitation of the percent of GFP-positive cells coexpressing specific markers. Fields were photographed using a Â 10 objective, with an average of about 300 cells per field. Cells were identified manually in Photoshop (Adobe Systems, San Jose, CA, USA) and quantitated using Image J software (National Institutes of Health, Bethesda, MD, USA).
Pharmacological inhibition of Pin1. Cortical progenitor cells were established from E13.5 CD1 embryos and plated at a density of 3 Â 10 5 cells/ml. Prior to treatment with the Pin1 inhibitor juglone, half of the culture medium was removed on day in vitro (DIV) 2, kept as conditioned medium, and replaced with fresh medium together with 5 mM juglone (Sigma-Aldrich) dissolved in DMSO, or DMSO alone. Six hours later, the medium was replaced with a 1 : 1 mix of fresh and conditioned medium. On DIV 5, cells were either fixed and subjected to immunocytochemical analysis or lysed for Western blot studies. Immunocytochemistry was performed using antibodies against Ki67, nestin, MAP2, or type III b-III-tubulin. For each condition and each antibody, 5 different fields were photographed using a 20X objective, with an average of about 300 cells per field. Cell counting was performed as described above. Western blot studies were conducted using the following antibodies: anti-phospho-histone H3 (1 : 2000; Millipore), anti-type III b-III-tubulin (1 : 10 000), anti-GAP-43 (1 : 2500; Millipore), and anti-b-actin (1 : 10 000; Abcam Inc., Toronto, ON, Canada).
Pin1 knockdown. Cortical progenitor cells were plated at a density of 2 Â 10 5 cells/ml. On DIV 2, half of the medium was removed and cells were transduced with lentivirus expressing either non-silencing shRNA (Sigma-Aldrich, Cat No. SGC202V) or Pin1 shRNA (Sigma-Aldrich, Cat No. TRCN0000321124), at a multiplicity of infection of 5. Five hours later, a volume of fresh medium equal to the volume of medium removed before transduction was added. On DIV 5 and 7, half of the medium was replaced with fresh medium. On DIV 8, cells were lysed and subjected to western blot analysis using antibodies against Pin1, phosphohistone H3, type III b-III-tubulin, GAP-43 and b-actin.
Statistical analysis. Statistical comparisons were made using two-tailed Student's t-test. All statistical tests were performed with GraphPad Prism software (GraphPad, La Jolla, CA, USA). Significance levels was set at Po0.05. Where appropriate, additional statistical details are provided in the figure legends.
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